Critical role of K1685 and K1829 in the large protein of rabies virus in viral pathogenicity and immune evasion

Journal of Virology

Volumn 90, Issue 1, 2016, Pages 232-244

  Tian, Dayong ^a   Luo, Zhaochen ^a   Zhou, Ming ^a   Li, Mingming ^a   Yu, Lan ^a   Wang, Chong ^a   Yuan, Jiaolong ^a   Li, Fang ^a   Tian, Bin ^a   Sui, Baokun ^a   Chen, Huanchun ^a   Fu, Zhen F ^a,b   Zhao, Ling ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; LARGE PROTEIN; PROTEIN IFIT2; UNCLASSIFIED DRUG; VIRUS PROTEIN; DNA DIRECTED RNA POLYMERASE; L PROTEIN, RABIES VIRUS; MUTANT PROTEIN; VIRAL PROTEIN; VIRULENCE FACTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE RAW 264.7; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HEK293 CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE EVASION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MOTIF; RABIES VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUCKLING ANIMAL; VIRUS MUTANT; VIRUS MUTATION; VIRUS RECOMBINANT; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DISEASE MODEL; DNA MUTATIONAL ANALYSIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; NEWBORN; PATHOLOGY; PHYSIOLOGY; RABIES; VIROLOGY;

ANIMALS; ANIMALS, NEWBORN; CELL LINE; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; DNA-DIRECTED RNA POLYMERASES; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; MICE, INBRED BALB C; MUTANT PROTEINS; RABIES; RABIES VIRUS; VIRAL PROTEINS; VIRULENCE FACTORS;

EID: 84953924201     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02050-15     Document Type: Article

References (52)

1. WHO. 2013.WHOExpert Consultation on Rabies. Second report. World Health Organ Tech Rep Ser 2013(982):1-139.
2. Wunner WH, Larson JK, Dietzschold B, Smith CL. 1988. The molecular biology of rabies viruses. Rev Infect Dis 10:771-784.
3. Wang ZW, Sarmento L, Wang Y, Li XQ, Dhingra V, Tseggai T, Jiang B, Fu ZF. 2005. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol 79:12554-12565. http://dx.doi.org/10.1128/JVI.79.19.12554-12565.2005.
4. Roy A, Phares TW, Koprowski H, Hooper DC. 2007. Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. J Virol 81:1110-1118. http://dx.doi.org/10.1128/JVI.01964-06.
5. Roy A, Hooper DC. 2008. Immune evasion by rabies viruses through the maintenance of blood-brain barrier integrity. J Neurovirol 14:401-411. http://dx.doi.org/10.1080/13550280802235924.
6. Miyamoto K, Matsumoto S. 1967. Comparative studies between pathogenesis of street and fixed rabies infection. J Exp Med 125:447-456. http://dx.doi.org/10.1084/jem.125.3.447.
7. Jackson AC. 2002. Rabies pathogenesis. J Neurovirol 8:267-269. http://dx.doi.org/10.1080/13550280290100725.
8. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801. http://dx.doi.org/10.1016/j.cell.2006.02.015.
9. Honda K, Takaoka A, Taniguchi T. 2006. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25:349-360. http://dx.doi.org/10.1016/j.immuni.2006.08.009.
10. Sadler AJ, Williams BR. 2008. Interferon-inducible antiviral effectors. Nat Rev Immunol 8:559-568. http://dx.doi.org/10.1038/nri2314.
11. Faul EJ, Wanjalla CN, Suthar MS, Gale M, Wirblich C, Schnell MJ. 2010. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog 6:e1001016. http://dx.doi.org/10.1371/journal.ppat.1001016.
12. Masatani T, Ito N, Shimizu K, Ito Y, Nakagawa K, Sawaki Y, Koyama H, Sugiyama M. 2010. Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response. J Virol 84:4002-4012. http://dx.doi.org/10.1128/JVI.02220-09.
13. Rieder M, Conzelmann KK. 2009. Rhabdovirus evasion of the interferon system. J Interferon Cytokine Res 29:499-509. http://dx.doi.org/10.1089/jir.2009.0068.
14. Rieder M, Brzózka K, Pfaller CK, Cox JH, Stitz L, Conzelmann KK. 2011. Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: inhibition of interferon regulatory factor 3 activation is important for pathogenicity. J Virol 85:842-852. http://dx.doi.org/10.1128/JVI.01427-10.
15. Lafon M. 2011. Evasive strategies in rabies virus infection. Adv Virus Res 79:33-53. http://dx.doi.org/10.1016/B978-0-12-387040-7.00003-2.
16. Brzózka K, Finke S, Conzelmann KK. 2005. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 79:7673-7681. http://dx.doi.org/10.1128/JVI.79.12.7673-7681.2005.
17. Rieder M, Conzelmann KK. 2011. Interferon in rabies virus infection. Adv Virus Res 79:91-114. http://dx.doi.org/10.1016/B978-0-12-387040-7.00006-8.
18. Vidy A, Chelbi-Alix M, Blondel D. 2005. Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J Virol 79:14411-14420. http://dx.doi.org/10.1128/JVI.79.22.14411-14420.2005.
19. Blondel D, Regad T, Poisson N, Pavie B, Harper F, PandolfiPP, de Thé H, Chelbi-Alix MK. 2002. Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 21: 7957-7970. http://dx.doi.org/10.1038/sj.onc.1205931.
20. Masatani T, Ito N, Shimizu K, Ito Y, Nakagawa K, Abe M, Yamaoka S, Sugiyama M. 2011. Amino acids at positions 273 and 394 in rabies virus nucleoprotein are important for both evasion of host RIG-I-mediated antiviral response and pathogenicity. Virus Res 155:168-174. http://dx.doi.org/10.1016/j.virusres.2010.09.016.
21. Li J, Fontaine-Rodriguez EC, Whelan SP. 2005. Amino acid residues within conserved domain VI of the vesicular stomatitis virus large polymerase protein essential for mRNA cap methyltransferase activity. J Virol 79:13373-13384. http://dx.doi.org/10.1128/JVI.79.21.13373-13384.2005.
22. Ferron F, Longhi S, Henrissat B, Canard B. 2002. Viral RNApolymerases-a predicted 2'-O-ribose methyltransferase domain shared by all Mononegavirales. Trends Biochem Sci 27:222-224. http://dx.doi.org/10.1016/S0968-0004(02)02091-1.
23. Bujnicki JM, Rychlewski L. 2002. In silico identification, structure prediction and phylogenetic analysis of the 2'-O-ribose (cap 1) methyltransferase domain in the large structural protein of ssRNA negative-strand viruses. Protein Eng 15:101-108. http://dx.doi.org/10.1093/protein/15.2.101.
24. Liang B, Li Z, Jenni S, Rahmeh AA, Morin BM, Grant T, GrigorieffN, Harrison SC, Whelan SP. 2015. Structure of the L protein of vesicular stomatitis virus from electron cryomicroscopy. Cell 162:314-327. http://dx.doi.org/10.1016/j.cell.2015.06.018.
25. Muthukrishnan S, Both GW, Furuichi Y, Shatkin AJ. 1975. 5'-Terminal 7-methylguanosine in eukaryotic mRNA is required for translation. Nature 255:33-37. http://dx.doi.org/10.1038/255033a0.
26. Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J, Lin TY, Schneller S, Zust R, Dong H, Thiel V, Sen GC, Fensterl V, Klimstra WB, Pierson TC, Buller RM, Gale M, Jr, Shi PY, Diamond MS. 2010. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468:452-456. http://dx.doi.org/10.1038/nature09489.
27. Züst R, Cervantes-Barragan L, Habjan M, Maier R, Neuman BW, Ziebuhr J, Szretter KJ, Baker SC, Barchet W, Diamond MS, Siddell SG, Ludewig B, Thiel V. 2011. Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol 12:137-143. http://dx.doi.org/10.1038/ni.1979.
28. Ma YM, Wei YW, Zhang XD, Zhang Y, Cai H, Zhu Y, Shilo K, Oglesbee M, Krakowka S, Whelan SPJ, Li JR. 2014. mRNA cap methylation influences pathogenesis of vesicular stomatitis virus in vivo. J Virol 88: 2913-2926. http://dx.doi.org/10.1128/JVI.03420-13.
29. Jiang D, Weidner JM, Qing M, Pan XB, Guo H, Xu C, Zhang X, Birk A, Chang J, Shi PY, Block TM, Guo JT. 2010. Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J Virol 84:8332-8341. http://dx.doi.org/10.1128/JVI.02199-09.
30. Zhang G, Wang H, Mahmood F, Fu ZF. 2013. Rabies virus glycoprotein is an important determinant for the induction of innate immune re-sponses and the pathogenic mechanisms. Vet Microbiol 162:601-613. http://dx.doi.org/10.1016/j.vetmic.2012.11.031.
31. Inoue K, Shoji Y, Kurane I, Iijima T, Sakai T, Morimoto K. 2003. An improved method for recovering rabies virus from cloned cDNA. J Virol Methods 107:229-236. http://dx.doi.org/10.1016/S0166-0934(02)00249-5.
32. Zhao L, Toriumi H, Kuang Y, Chen H, Fu ZF. 2009. The roles of chemokines in rabies virus infection: overexpression may not always be beneficial. J Virol 83:11808-11818. http://dx.doi.org/10.1128/JVI.01346-09.
33. Zhao L, Toriumi H, Wang H, Kuang Y, Guo X, Morimoto K, Fu ZF. 2010. Expression of MIP-1α (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells. J Virol 84:9642-9648. http://dx.doi.org/10.1128/JVI.00326-10.
34. Kuang Y, Lackay SN, Zhao L, Fu ZF. 2009. Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection. Virus Res 144:18-26. http://dx.doi.org/10.1016/j.virusres.2009.03.014.
35. Kimura T, Katoh H, Kayama H, Saiga H, Okuyama M, Okamoto T, Umemoto E, Matsuura Y, Yamamoto M, Takeda K. 2013. Ifit1 inhibits Japanese encephalitis virus replication through binding to 5' capped 2'-O unmethylated RNA. J Virol 87:9997-10003. http://dx.doi.org/10.1128/JVI.00883-13.
36. Poch O, Blumberg BM, Bougueleret L, Tordo N. 1990. Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains. J Gen Virol 71(Part 5):1153-1162.
37. Decroly E, Ferron F, Lescar J, Canard B. 2011. Conventional and unconventional mechanisms for capping viral mRNA. Nat Rev Microbiol 10:51-65. http://dx.doi.org/10.1038/nrmicro2675.
38. Li J, Wang JT, Whelan SP. 2006. A unique strategy for mRNA cap methylation used by vesicular stomatitis virus. Proc Natl Acad Sci U S A 103:8493-8498. http://dx.doi.org/10.1073/pnas.0509821103.
39. Li J, Rahmeh A, Morelli M, Whelan SP. 2008. A conserved motif in regionVof the large polymerase proteins of nonsegmented negative-sense RNA viruses that is essential for mRNA capping. J Virol 82:775-784. http://dx.doi.org/10.1128/JVI.02107-07.
40. Albertini AA, Ruigrok RW, Blondel D. 2011. Rabies virus transcription and replication. Adv Virus Res 79:1-22. http://dx.doi.org/10.1016/B978-0-12-387040-7.00001-9.
41. Li SH, Dong H, Li XF, Xie X, Zhao H, Deng YQ, Wang XY, Ye Q, Zhu SY, Wang HJ, Zhang B, Leng QB, Zuest R, Qin ED, Qin CF, Shi PY. 2013. Rational design of a flavivirus vaccine by abolishing viral RNA 2'-O methylation. J Virol 87:5812-5819. http://dx.doi.org/10.1128/JVI.02806-12.
42. Züst R, Dong H, Li XF, Chang DC, Zhang B, Balakrishnan T, Toh YX, Jiang T, Li SH, Deng YQ, Ellis BR, Ellis EM, Poidinger M, Zolezzi F, Qin CF, Shi PY, Fink K. 2013. Rational design of a live attenuated dengue vaccine: 2'-O-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques. PLoS Pathog 9:e1003521. http://dx.doi.org/10.1371/journal.ppat.1003521.
43. Zhou Y, Ray D, Zhao Y, Dong H, Ren S, Li Z, Guo Y, Bernard KA, Shi PY, Li H. 2007. Structure and function of flavivirus NS5 methyltransferase. J Virol 81:3891-3903. http://dx.doi.org/10.1128/JVI.02704-06.
44. Ray D, Shah A, Tilgner M, Guo Y, Zhao Y, Dong H, Deas TS, Zhou Y, Li H, Shi PY. 2006. West Nile virus 5'-cap structure is formed by sequential guanine N-7 and ribose 2'-O methylations by nonstructural protein 5. J Virol 80:8362-8370. http://dx.doi.org/10.1128/JVI.00814-06.
45. Chen Y, Su C, Ke M, Jin X, Xu L, Zhang Z, Wu A, Sun Y, Yang Z, Tien P, Ahola T, Liang Y, Liu X, Guo D. 2011. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-Omethylation by nsp16/nsp10 protein complex. PLoS Pathog 7:e1002294. http://dx.doi.org/10.1371/journal.ppat.1002294.
46. Decroly E, Debarnot C, Ferron F, Bouvet M, Coutard B, Imbert I, Gluais L, Papageorgiou N, SharffA, Bricogne G, Ortiz-Lombardia M, Lescar J, Canard B. 2011. Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2'-O-methyltransferase nsp10/nsp16 complex. PLoS Pathog 7:e1002059. http://dx.doi.org/10.1371/journal.ppat.1002059.
47. Furuichi Y, Shatkin AJ. 2000. Viral and cellular mRNA capping: past and prospects. Adv Virus Res 55:135-184. http://dx.doi.org/10.1016/S0065-3527(00)55003-9.
48. Menachery VD, Yount BL, Josset L, Gralinski LE, Scobey T, Agnihothram S, Katze MG, Baric RS. 2014. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-Omethyltransferase activity. J Virol 88:4251-4264. http://dx.doi.org/10.1128/JVI.03571-13.
49. Diamond MS, Farzan M. 2013. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 13:46-57. http://dx.doi.org/10.1038/nri3344.
50. Fensterl V, Sen GC. 2011. The ISG56/IFIT1 gene family. J Interferon Cytokine Res 31:71-78. http://dx.doi.org/10.1089/jir.2010.0101.
51. Wacher C, Muller M, Hofer MJ, Getts DR, Zabaras R, Ousman SS, Terenzi F, Sen GC, King NJ, Campbell IL. 2007. Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J Virol 81:860-871. http://dx.doi.org/10.1128/JVI.01167-06.
52. Fensterl V, Wetzel JL, Ramachandran S, Ogino T, Stohlman SA, Bergmann CC, Diamond MS, Virgin HW, Sen GC. 2012. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog 8:e1002712. http://dx.doi.org/10.1371/journal.ppat.1002712.